Searched for: in-biosketch:yes
person:chakra01
Linkage mapping of the carbonyl reductase (CBR) gene on human chromosome 21 using a DNA polymorphism in the 3' untranslated region
Avramopoulos, D; Cox, T; Forrest, G L; Chakravarti, A; Antonarakis, S E
A DNA polymorphism has been found in the 3' untranslated region of the carbonyl reductase gene (CBR). Genotypes of the members of the CEPH pedigrees have been obtained and used in linkage analysis to map the CBR gene in the linkage map of human chromosome 21. The gene maps between the interferon-alpha receptor (IFNAR) and the D21S55 loci.
PMID: 1612603
ISSN: 0888-7543
CID: 3975292
D21S215 is a (GT)n polymorphic marker close to centromeric alphoid sequences on chromosome 21
Warren, A C; Petersen, M B; Van Hul, W; McInnis, M G; Van Broeckhoven, C; Cox, T K; Chakravarti, A; Antonarakis, S E
A plasmid, AWZ1, that contained a dinucleotide (GT)n repeat was identified from a chromosome 21-specific genomic library. When amplified by PCR from human genomic DNA, the repeat length was highly polymorphic between individuals; its location, D21S215, was mapped in the CEPH pedigrees by linkage analysis to the pericentromeric region of chromosome 21. It is the closest polymorphic marker to alphoid sequences on this chromosome.
PMID: 1505976
ISSN: 0888-7543
CID: 3975282
Cloning and linkage mapping of three polymorphic tetranucleotide (TAAA)n repeats on human chromosome 21
Kalaitsidaki, M; Cox, T; Chakravarti, A; Antonarakis, S E
We report the cloning, sequencing, and mapping of three short sequence repeat polymorphisms due to tetranucleotide (TAAA)n repeats from human chromosome 21. These DNA markers (D21S221, D21S225, D21S226) have been cloned from the chromosome 21-specific plasmid library of J. C. Fuscoe, C. C. Collins, D. Pinkel, and J. W. Gray (1989, Genomics 5: 100-109) and were shown to be polymorphic by polymerase chain reaction amplification and polyacrylamide gel electrophoresis. Genotypes were determined in informative CEPH pedigrees and used in linkage analysis relative to other mapped markers on human chromosome 21. One of these markers, D21S221, is closely linked to the amyloid precursor protein gene (APP), which has been implicated in the etiology of familial Alzheimer disease in some families.
PMID: 1478649
ISSN: 0888-7543
CID: 3975272
Dinucleotide repeat (GT)n markers on chromosome 21
Warren, A C; McInnis, M G; Blaschak, J; Kaliatsidaki, M; Petersen, M B; Chakravarti, A; Antonarakis, S E
To further develop the linkage map of human chromosome 21 (HC21), we have concentrated on identifying highly polymorphic markers based on dinucleotide repeat sequences such as (GT)n, as these are often highly polymorphic, are widespread throughout the human genome, and can be rapidly analyzed by the polymerase chain reaction. We report here nine (GT)n polymorphic markers from HC21.
PMID: 1427915
ISSN: 0888-7543
CID: 3975262
Linkage mapping of the AML1 gene on human chromosome 21 using a DNA polymorphism in the 3' untranslated region
Avramopoulos, D; Cox, T; Blaschak, J E; Chakravarti, A; Antonarakis, S E
We have detected a polymorphism in the 3' untranslated region of the AML1 gene, which is located at the breakpoint on chromosome 21 in the t(8;21)(q22;q22.3) translocation often associated with patients with acute myeloid leukemia. Informative CEPH families were genotyped for this polymorphism and used to localize the gene on the linkage map of human chromosome 21. The AML1 gene is located between the markers D21S216 and D21S211, in chromosomal band 21q22.3.
PMID: 1427868
ISSN: 0888-7543
CID: 3975252
Chromosome 21 genetic linkage data set based on CEPH pedigrees
Warren, A C; Antonarakis, S E; Chakravarti, A
PMID: 1737517
ISSN: 0301-0171
CID: 3975652
The gene order problem when using somatic cell hybrids
Aston, C E; Chakravarti, A
PMID: 1737518
ISSN: 0301-0171
CID: 3975662
A theory for radiation hybrid (Goss-Harris) mapping: application to proximal 21q markers
Chakravarti, A; Reefer, J E
PMID: 1737521
ISSN: 0301-0171
CID: 3975672
NORMAL FINDINGS 52 YEARS AFTER INUTERO RADIATION EXPOSURE [Letter]
MULVIHILL, JJ; HARVEY, EB; BOICE, JD; CHAKRAVARTI, A; MILLER, RW
ISI:A1991GP03400024
ISSN: 0140-6736
CID: 3981962
Parental origin of the extra chromosome in trisomy 21 as indicated by analysis of DNA polymorphisms. Down Syndrome Collaborative Group
Antonarakis, S E; [Chakravarti, A]
BACKGROUND:Over the past 20 years, the parental origin of the extra chromosome in children with trisomy 21 has been investigated with cytogenetic methods of identifying morphologic variations in chromosome 21. These studies have concluded that the origin of the extra chromosome 21 was maternal in approximately 80 percent of cases and paternal in about 20 percent. METHODS:We studied 200 families, each with a single child with trisomy 21, using DNA polymorphisms as markers to determine the parental origin of the nondisjunction causing the extra chromosome 21. These polymorphisms spanned a region of about 120 centimorgans on the long arm of chromosome 21, from the D21S13 locus (the most centromeric) to the COL6A1 gene (the most telomeric). RESULTS:The parental origin of nondisjunction could be determined for all but 7 of the 200 children. It was maternal in 184 children (proportion [+/- SE], 95.3 +/- 1.5 percent) and paternal in 9 (4.7 +/- 1.5 percent). In a subgroup of 31 families, we compared the results of DNA analysis with those of traditional cytogenetic analysis. According to the cytogenetic analyses, nondisjunction originated in the mother in 26 cases (84 percent) and in the father in 5 (16 percent). DNA analysis demonstrated the origin as maternal in 29 (94 percent) and paternal in 2 (6 percent). With the cytogenetic analyses, there were three false determinations of paternal origin. CONCLUSIONS:In trisomy 21 the extra chromosome 21 is maternal in origin in about 95 percent of the cases, and paternal in only about 5 percent--considerably less than has been reported with cytogenetic methods. DNA polymorphic analysis is now the method of choice for establishing the parental origin of nondisjunction.
PMID: 1825697
ISSN: 0028-4793
CID: 3982012